Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,512,259 High strength polyurethane foam compositions and methods
Disclosed are high strength polyurethane foam compositions and methods of making them. In one aspect, the inventive polyurethane foams include strength...
US-9,512,258 Process for the production of viscoelastic polyurethane foam
The present invention provides a process for the production of a viscoelastic flexible polyurethane foam. The invention further relates to a viscoelastic...
US-9,512,257 Halogen-free, nonflammable and high glass transition temperature phenolic resin-based curing agent and process...
A phenolic-type phosphorous curing agent works by grafting a phosphorous compound onto a benzene ring to substitute hydrogen atoms and is halogen-free and...
US-9,512,256 Dichloroamino-functionalized fluoropolymer and process for preparing
This invention pertains to a novel fluoropolymer characterized by a dichloroamino-functionalized perfluoroether pendant group that terminates in...
US-9,512,255 Vinylidene fluoride copolymers and uses of the copolymers
Provided are vinylidene fluoride copolymers exhibiting higher adhesion with respect to metal foils than do conventional vinylidene fluoride copolymers, and to...
US-9,512,254 Increased polymer melt flow ratio via feed of a supported catalyst saturated with a selected liquid agent
A process for the production of ethylene alpha-olefin copolymers is disclosed. The process may include feeding a catalyst system comprising a supported...
US-9,512,253 Polypropylene composition with improved sealing and thermal properties
The present invention relates to a polypropylene composition comprising comonomer units derived from ethylene in an amount of from 0.5 wt % to 25 wt %, and from...
US-9,512,252 Bis-imine complex of lanthanides, catalytic system comprising said bis-imine complex and process for the...
A bis-imine complex of lanthanides having general formula (I): Said bis-imine complex of lanthanides having general formula (I) can be advantageously used in a...
US-9,512,251 Polymerizable compound, polymerizable composition, polymer, and optically anisotropic material
The present invention relates to: a polymerizable compound (I), wherein Y.sup.1 to Y.sup.6 are a chemical single bond, --O--C(.dbd.O)--, --C(.dbd.O)--O-- or the...
US-9,512,250 Manganese catalyzed photopolymerization of fluorinated monomers
The disclosure discloses initiating systems for the radical polymerization of alkenes, and especially fluorine substituted alkenes. The polymerization is...
US-9,512,249 Bio-based block polymers derived from lignin and fatty acids
The present invention pertains to bio-based block polymers synthesized from functionalized lignin-based molecules (A-monomer) and functionalized fatty acids or...
US-9,512,248 Mixed decyl mercaptans compositions and use thereof as chain transfer agents
A chain transfer agent composition comprises at least one branched C.sub.10 mercaptan selected from 5-methyl-1-mercapto-nonane, 3-propyl-1-mercapto-heptane,...
US-9,512,247 (Meth)acryloyl-terminated polyisobutylene polymer, method for producing the same, and active energy ray-curable...
The purpose of the present invention is to provide a polymer having a low halogen atom content remaining in the polymer, a simple production method thereof, an...
US-9,512,246 Process for the preparation of polypropylene with improved productivity
A process for the preparation of a polypropylene in a sequential polymerization process including a pre-polymerization reactor and at least two polymerization...
US-9,512,245 Catalyst slurry preparation system and use thereof
A process includes preparing a diluted catalyst slurry in a catalyst slurry preparation system. The diluted catalyst slurry contains solid particulate catalyst...
US-9,512,244 Process for preparing a catalyst component for propylene polymerization
The invention relates to a process for preparing a polymerization catalyst component wherein a solid compound with formula Mg(OR.sup.1).sub.xCl.sub.2-x wherein...
US-9,512,243 Methods for using silver-containing polymeric complexes
A method can be used to provide electrically-conductive articles with electrolessly plated metal, or articles having antimicrobial properties for marine...
US-9,512,242 Polymerizable oligomer and photoresist composition comprising the same
The embodiments of the invention provide a polymerizable oligomer and a photoresist composition including the polymerizable oligomer, wherein the polymerizable...
US-9,512,241 Method for reducing odoriferous and/or toxic residual monomer in a latex
The present invention relates to a new and efficient toxicity and/or odor reducing method for ethyl acrylate and/or acrylonitrile contained aqueous polymer...
US-9,512,240 Process for the production of water and solvent-free polymers
The present invention relates to water and solvent-free polymers, in particular water and solvent-free synthetic rubber products like non-halogenated and...
US-9,512,239 Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
Compositions for improving the health of a subject comprise alpha-(1,2)-branched alpha-(1,6) oligodextrans, preferably with an average molecular weight between...
US-9,512,238 Cellulose resin and method for producing the same
A cellulose resin produced by binding cardanol or a derivative thereof to cellulose or a derivative thereof with the use of a cellulose hydroxy group of the...
US-9,512,237 Method for inhibiting the growth of microbes with a modified cellulose fiber
A method of inhibiting the growth of bacteria in an absorbent device by using kraft pulp fiber subjected to an acidic, catalyzed peroxide treatment process...
US-9,512,236 Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of...
The present invention relates to amino acid sequences that are directed against G-protein coupled receptors (GPCRs), as well as to compounds or constructs, and...
US-9,512,235 RNA-specific binding antibody
The present invention relates to an antibody being capable of binding specifically to BC200 RNA or its antigen binding fragment, a polynucleotide of encoding...
US-9,512,234 Methods for treating colon cancer and inflammation associated with overexpression of human signal...
The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides...
US-9,512,233 Anti-complement C1s antibodies and methods of inhibiting complement C1s activity
The present disclosure provides antibodies that bind complement C1s protein; and nucleic acid molecules that encode such antibodies. In some embodiments, such...
US-9,512,232 Antibodies against Claudin 18.2 useful in cancer diagnosis
The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN18.2 which are useful, for example, in diagnosing...
US-9,512,231 Cross-linking polypeptide that induces apoptosis
The disclosure relates to a polypeptide comprising at least four domains specifically binding to a certain MHC peptide complex, the domains separated by linker...
US-9,512,230 Transcription units and the use thereof in expression vectors
Novel transcription units that may be used in expression vectors. The transcription unit allow antibodies to be produced whose gain in productivity is not...
US-9,512,229 Synergistic combinations of OX40L antibodies for the treatment of GVHD
The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
US-9,512,228 Selective elimination of erosive cells
The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention...
US-9,512,227 Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a...
US-9,512,226 Agent for treating disease
The present invention provides a pharmaceutical composition for treating an autoimmune disease comprising a pharmaceutically acceptable carrier and an agent...
US-9,512,225 Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a...
US-9,512,224 Use of semaphorin-4D binding molecules for treatment of atherosclerosis
Provided herein are methods for reducing, inhibiting, suppressing and/or delaying atherosclerotic plaque growth or neovascularization in a subject having...
US-9,512,223 Methods for treatment of gastric cancer
The application provides methods of detection, diagnosis, prognosis, prophylaxis and treatment of folate receptor-alpha-expressing gastric cancer using...
US-9,512,222 Lectin-like oxidized LDL receptor 1 antibodies and methods of use
The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes...
US-9,512,221 Anti-TLR4 antibodies and methods of use thereof
This invention relates generally to antibodies that specifically bind Toll-like Receptor 4 (TLR-4), and to methods of using the anti-TLR4 antibodies as...
US-9,512,220 Antibodies against angiopoietins 1 and 2, and their use
The present invention relates to antibodies against angiopoietins 1 and 2, and derivatives of these antibodies. More specifically, the present invention relates...
US-9,512,219 IL-31 monoclonal antibodies
The present invention relates to methods of treating pruritic diseases, including but not limited to Contact dermatitis, Atopic Dermatitis, Drug induced delayed...
US-9,512,218 Use of IL-20 antagonists for alleviating spinal cord injury
Alleviating neural injury, such as spinal cord injury, in a subject (e.g., a human subject) in need of the treatment using an IL-20 antagonist, which can be an...
US-9,512,217 Antibodies binding to IL-17A
The present invention relates generally to antibodies cross-reactive with IL-17A and IL-17F, and bispecific anti-IL-17A/F and their uses.
US-9,512,216 Use of TNF.alpha. inhibitor
The invention describes methods of treating erosive polyarthritis comprising administering a TNF.alpha. antibody, or antigen-binding portion thereof. The...
US-9,512,215 Liquid formulations of tumor necrosis factor-binding proteins
The invention relates to a stable, pharmaceutically acceptable, aqueous formulation of TNF-binding protein, comprising a TNF-binding protein, a buffer and an...
US-9,512,214 Methods to control protein heterogeneity
The instant invention relates to the field of protein production and in particular to controlled protein heterogeneity compositions and processes for...
US-9,512,213 Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated...
Compositions and methods are disclosed herein for producing one or more immunoglobulins in an isolated B lymphocyte cell line. An isolated cell line includes an...
US-9,512,212 Bispecific antibody fragments for neurological disease proteins and methods of use
The present invention relates to therapeutic agents comprising bispecific recombinant antibody fragments to selectively clear a protein associated with a...
US-9,512,211 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
Antibodies and antigen binding fragments that specifically bind to clusterin are described. In some embodiments, the antibodies block the biological activity of...
US-9,512,210 Immunoglobulin constant region Fc receptor binding agents
IVIG replacement compounds are derived from recombinant and/or biochemical creation of immunologically active biomimetic(s). These replacement compounds are...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.